Lv3
274 积分 2022-08-31 加入
A Novel Dual-Payload ADC Platform Integrating Exatecan and Triptolide to Enhance Antitumor Efficacy and Overcome Resistance
2个月前
已完结
Extracellular targeted protein degradation: an emerging modality for drug discovery
2个月前
已完结
To degrade or not to degrade: mechanisms and significance of endocytic recycling
2个月前
已完结
Extracellular targeted protein degradation: an emerging modality for drug discovery
2个月前
已完结
To degrade or not to degrade: mechanisms and significance of endocytic recycling
2个月前
已完结
Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
2个月前
已完结
An array of 60,000 antibodies for proteome-scale antibody generation and target discovery
2个月前
已完结
Altering Antibody-Drug Conjugate Binding to the Neonatal Fc Receptor Impacts Efficacy and Tolerability
2个月前
已完结
Spatiotemporal Quantification of HER2-targeting Antibody–Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration
5个月前
已完结
Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase II alpha, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas
7个月前
已完结
皖公网安备34019202002308
